Herb–Drug Interactions and Supplement Quality

What this means

An herb or dietary supplement can change how a prescription or over-the-counter drug is absorbed, broken down, or felt. Some interactions lower drug levels and reduce benefit. Others add sedation, bleeding, blood-pressure shifts, glucose changes, or organ strain. St. John’s wort is a well-documented example because it can induce enzymes and transporters involved in many medicines.

Quality is a separate problem from interaction potential. In the United States, dietary supplements generally do not receive FDA premarket approval for safety and effectiveness the way drugs do. Labels can be incomplete. Products marketed for weight loss, sexual enhancement, or bodybuilding are repeatedly found with hidden drug ingredients.

A longevity clinic that sells teas, tinctures, or capsules is still in this landscape. Complementary use next to standard care is not automatically safe. The combination of an herb plus an anticoagulant, a transplant medicine, or chemotherapy can matter more than the wellness story on the bottle.

This page is for patients who take, or are being offered, herbs and supplements alongside clinic care. It is not a list of products to start. It is a request that a pharmacist or licensed clinician review the full stack before you add, stack, or substitute anything sold as natural.

What the evidence shows

NCCIH and the NIH Office of Dietary Supplements describe St. John’s wort as an inducer that can reduce concentrations of many drugs. Clinically important examples in professional materials include some oral contraceptives, cyclosporine and other transplant medicines, and certain antiretrovirals. Treatment failure, not a gentle mood lift, is the interaction risk that matters.

Herb–drug interaction mechanisms are broader than one plant. Enzyme induction or inhibition, transporter effects, and additive pharmacologic effects all occur. Bleeding-risk herbs and high-dose fish oil or vitamin E can matter around surgery even without a classic metabolic interaction. Sedating herbs can add to opioids, benzodiazepines, or alcohol.

NCCIH’s clinician digest on herb–drug interactions treats these as medication-safety problems, not as proof that herbs never help. The evidence for a given product is condition-specific. A plausible mechanism is not the same as a trial in your situation. Unknown product content makes even a well-studied herb harder to use safely.

FDA consumer pages on dietary supplements emphasize that manufacturers are responsible for product safety and labeling, and that the agency does not approve supplements before they are marketed. Third-party programs such as USP or NSF can add information about identity and contaminants for certified products. They do not validate disease claims.

Common myths

A common myth is that natural means it cannot interact. Plants contain bioactive compounds. St. John’s wort is the teaching case, but it is not the only one. If a product is strong enough to change how you feel, it may be strong enough to change a drug level or a bleeding risk.

Another myth is that a clinic protocol has already checked interactions because the bottle is on their shelf. Shelf placement is inventory. Interaction review requires your exact medicines, doses, and timing. Proprietary blends that hide milligram amounts make that review harder, not more advanced.

People also assume independent certification means the supplement treats a disease. Certification, when current and lot-relevant, speaks to selected quality tests. It does not replace a diagnosis, and it does not make a cancer, infection, or transplant medicine optional. Quality and effectiveness are different claims.

A fourth myth is that stopping a prescribed drug so an herb can work is integrative care. That is substitution. NCCIH advises against using an unproven product as a reason to postpone indicated treatment. Coordinate changes with the prescriber. Do not taper anticoagulants, insulin, or transplant drugs from a wellness visit.

How clinics use it

Some clinics treat supplement review as medication reconciliation. They collect every bottle, check interactions, simplify duplicates, and document what you will stop, continue, or trial for a defined period. A pharmacist-accessible workflow is a quality signal. So is willingness to call your other clinicians.

Other clinics add herbs to every plan. That increases interaction surface area. Ask which product is for which symptom, what evidence supports that use, and what would make them discontinue it. A stack that cannot be justified item by item is a retail bundle.

Watch for high-risk settings: upcoming surgery or dental extraction, pregnancy, chemotherapy, anticoagulation, and transplant. Bleeding-risk herbs belong in the preoperative conversation. St. John’s wort belongs in any visit involving hormonal contraception or immunosuppressants. A clinic that never asks about those contexts is not reviewing safely.

FDA has warned consumers about tainted products in weight-loss, sexual-enhancement, and bodybuilding categories. A longevity menu that leans on those promises deserves extra skepticism. Hidden pharmaceuticals are an interaction and a contamination problem at once.

Practical takeaway

Make a single list: prescriptions, over-the-counter drugs, herbs, teas marketed as medicinal, and powders. Include brand, dose, frequency, and lot when you can. Bring it to a pharmacist or licensed clinician before a new clinic protocol. ODS fact sheets are useful background. They do not replace that person.

Ask specifically about St. John’s wort, bleeding-risk products, and anything you take for sleep, mood, or pain. Ask what to pause before a procedure and when to restart. Do not stop a prescribed medicine because an herb is described as cleansing. Set a review date for any new supplement, just as you would for a new drug.

Prefer products with transparent ingredient amounts and, when you use them, current independent quality certification. Avoid disease-cure claims and products that promise rapid weight loss or sexual enhancement. Report serious adverse events through medical care and FDA MedWatch when appropriate. Keep the bottle.

Complementary care still means your indicated medicines continue unless the prescriber changes them. If a clinic will not share the herb list with your physician, nurse practitioner, or physician assistant, treat that as a reason to pause. Interaction review is ordinary safety work, not optional extra caution.